These results underscore the pivotal role that EZH2 plays in orchestrating histone trimethylation, mirroring observations previously documented in the context of adult AML/MDS patients [23,24,25] and highlighting its potential as a prognostically relevant marker in myeloid neoplasms. This evidence concerns the gene EZH2 and acute myeloid leukemia.